Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2( ) metastatic breast cancer (Q44195525)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2002
edit
Language Label Description Also known as
English
Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2( ) metastatic breast cancer
scientific article published in January 2002

    Statements

    Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2( ) metastatic breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit